The characteristic changes of GLP-1 face include 4,5 : Facial volume loss, particularly in the midface Periocular hollowing and periorbital volume depletion Dermal thinning with loss of collagen and elastin fibers Decreased skin elasticity leading to redundant skin folds Accelerated appearance of aging As a result of these facial changes, GLP-1 agonist medications can result in an older, haggard and tired looking appearance
BPC-157 assists in maintaining magnesium levels, which is essential for muscle and nerve function, as well as a healthy immune system
In addition, do not use if you have: multiple endocrine neoplasia type 2 (tumors in your glands) a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer) diabetic ketoacidosis (call your doctor for treatment)
A short, targeted routine built around your actual symptoms and tested deficiencies almost always beats an expensive everything-bundle
Early morning or before bedtime is usually ideal
The prudent approach is to restart at one step below your maintenance dose and hold for two weeks before returning to the target level